CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
High ImpactOriginal article

Implantica receives FDA approval for RefluxStop® - Opening the U.S. market

RegulatoryapprovedRefluxStop®Positive
AI Analysis

Summary

Implantica AG announced FDA Premarket Approval for RefluxStop®, enabling the company to enter the U.S. market with this medtech device.

Outcome Details

FDA granted Premarket Approval (PMA) for RefluxStop®

Importance:8/10
Sentiment:
0.90
FDA approvalPMARefluxStopmedical deviceUS market entry

Read the original article

Published by PR Newswire Biotech on August 21, 2026 3:36 AM

Read Original